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Signal detection in clinical trials relies on ratings reliability. We conducted a reliability analysis of
site-independent rater scores derived from audio-digital recordings of site-based rater interviews of
the structured Brief Psychiatric Rating Scale (BPRS) in a schizophrenia study. “Dual” ratings
assessments were conducted as part of a quality assurance program in a 12-week, double-blind,
parallel-group study of PF-02545920 compared to placebo in patients with sub-optimally controlled
symptoms of schizophrenia (ClinicalTrials.gov identiﬁer NCT01939548). Blinded, site-independent
raters scored the recorded site-based BPRS interviews that were administered in relatively stable
patients during two visits prior to the randomization visit. We analyzed the impact of BPRS inter-
view length on “dual” scoring variance and discordance between trained and certiﬁed site-based
raters and the paired scores of the independent raters.
Mean total BPRS scores for 392 interviews conducted at the screen and stabilization visits were
50.477.2 (SD) for site-based raters and 49.277.2 for site-independent raters (t=2.34; p=0.025).
“Dual” rated total BPRS scores were highly correlated (r=0.812). Mean BPRS interview length was
21:0577:47 min ranging from 7 to 59 min. 89 interviews (23%) were conducted in less than 15 min.
These shorter interviews had signiﬁcantly greater “dual” scoring variability (p=0.0016) and absolute
discordance (p=0.0037) between site-based and site-independent raters than longer interviews.
In-study ratings reliability cannot be guaranteed by pre-study rater certiﬁcation. Our ﬁndings reveal
marked variability of BPRS interview length and that shorter interviews are often incomplete
yielding greater “dual” scoring discordance that may affect ratings precision.
& 2014 Elsevier B.V. and ECNP. Open access under CC BY-NC-ND license.o.2014.11.023
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Randomized clinical trials conducted for central nervous
system (CNS) indications depend on scoring reliability and
ratings consistency to evaluate the efﬁcacy of a candidate-ND license.
313Impact of BPRS interview length on ratings reliability in a schizophrenia trialdrug (Kobak et al., 2005; Targum, 2006; Targum et al.,
2013). Although the research instruments used to score
CNS symptoms are usually structured and standardized and
the raters are trained and certiﬁed beforehand, each
interview is likely to differ because of the nature of the
disease under study. In schizophrenia studies, patients may
be more or less informative and/or cooperative from visit
to visit such that raters may be challenged to conduct
complete and reliable interviews. The core features of
the illness itself (suspiciousness, negative symptoms, con-
ceptual disorganization) may complicate the reliability
and consistency of ratings. Beyond patient-related factors,
the competency of the clinician-rater to conduct research
interviews may also affect ratings reliability (Kobak et al.,
2005; Targum, 2006).
It is known that inter-rater reliability directly affects the
power of the test to achieve signal detection (Muller and
Szegedi, 2002). Despite the best efforts of pre-study rater
training and inter-rater reliability assessments, the quality of
in-study interviews still varies from rater to rater and may also
vary from visit to visit. It is conceivable that the pressure to
conduct a complete research interview during a busy clinic
day may result in shorter interviews that might compromise
ratings reliability. The same rater may conduct some good and
some less good interviews based upon the daily circumstances.
Recently, surveillance strategies using site-independent raters
have been used in clinical trials in an attempt to assure in-
study ratings quality and enhance precision throughout the
trial (Shen et al., 2008; Schoemaker et al., 2009; Sharp et al.,
2011; Targum and Pendergrass, 2014; Targum et al., 2014).
Site-independent scoring, including video-conferencing and
secondary telephone interviews have been used in the assess-
ment of patients with schizophrenia as well (Zarate et al.,
1997; Shen et al., 2008; Schoemaker et al., 2009; Sharp et al.,
2011; Targum et al., 2012). Each surveillance strategy has
potential beneﬁts and inherent limitations (Sharp et al., 2011;
Targum and Pendergrass, 2014). Given the nature of the illness
of schizophrenia and the inherent complexity of research
study visits, it would be desirable to minimize the extra bur-
den of a second, independent interview in patients with schi-
zophrenia.
We have explored the utility of audio-digital recording of
site-based interviews in randomized clinical trials (Targum
et al., 2012; Targum and Pendergrass, 2014; Targum et al.,
2014). A review of the primary, site-based rater's interview by
a paired independent rating of the same interview (“dual”
scoring) can be a reasonable metric to examine ratings reli-
ability (precision), to explore “dual” scoring discordance, and
to identify individual site-based rater's who reveal excessive
scoring discordance (“outlier's”). In the current study, we ass-
essed ratings reliability of the structured Brief Psychiatric
Rating Scale (BPRS) in the pre-randomization phase of a
schizophrenia trial using the audio-digital recording method
(Overall and Gorham, 1988; Targum and Pendergrass, 2014).
The recording method allowed us to examine the impact of
BPRS interview length as it related to interviewing competency
and scoring concordance. Our ﬁndings reveal that independent
scoring based upon audio-digital recordings can usually conﬁrm
the scores from most BPRS interviews but that some shorter
interviews are insufﬁcient and generate signiﬁcantly greater
“dual” scoring discordance. The in-study identiﬁcation of poorratings performance and early remediation of rater “outliers”
may enhance ratings precision for a clinical trial.2. Experimental methods
This study was conducted as part of a quality assurance
(QA) surveillance strategy in patients with relatively
stable symptoms of schizophrenia. Ratings reliability was
evaluated during a 12-week, double blind, parallel-group
study of PF-02545920 compared to placebo in patients
with sub-optimally controlled symptoms of schizophrenia
(ClinicalTrials.gov identiﬁer NCT01939548). The study was
conducted in compliance with the informed consent regula-
tions of an Institutional Review Board (IRB) and International
Conference on Harmonization (ICH) for Good Clinical Practice
(GCP) Guidelines at 26 clinical trial sites in the United States.
All study eligible patients needed to meet DSM-IV criteria for
schizophrenia based upon diagnostic conﬁrmation with the
Mini-International Psychiatric Interview (M.I.N.I.) and have
a minimum total Brief Psychiatric Rating Scale (BPRS)
scoreZ39 at the screening, stabilization, and randomization
visits (Lukoff et al., 1986; Overall and Gorham, 1988; Sheehan
et al., 1998). The BPRS score was used to conﬁrm symptom
stability between visits and was part of the eligibility criteria
for subject selection prior to randomization (visit 3) for this
particular study. The stabilization visit (visit 2) was conducted
a minimum of 14 days after the screen visit to re-assess BPRS
scores and conﬁrm relative symptom stability between these
visits. The BPRS was chosen as the symptom severity measure
to ascertain subject eligibility in order to un-couple the
eligibility criteria from the primary efﬁcacy measure. The
Positive and Negative Syndrome scale (PANSS) was the primary
efﬁcacy measure and was not administered until the randomi-
zation visit (Kay et al., 1987). Consequently, we used the
BPRS scores to examine symptom stability and “dual” ratings
precision prior to randomization.
All raters participated in a comprehensive rater training and
certiﬁcation program that was conducted at the study initiation
for all rating instruments, and included the BPRS and PANSS
(Overall and Gorham, 1988; Kay et al., 1987). All qualiﬁed site-
based and site-independent raters had at least two years
experience with the BPRS and primary measure (PANSS) and
needed to demonstrate scoring accuracy on sample video inter-
views of the BPRS and PANSS (inter-rater reliability) as well as
interviewing competency via mock interviews. The rater-training
program used structured versions of the BPRS (version 4.0) and
PANSS (Lukoff et al., 1986; Kay et al., 1987; Ventura et al., 1993;
Crippa et al., 2001). Light's weighted kappa scores demonstrated
inter-rater reliability for the BPRS ratings (κ=0.809) and PANSS
(κ=0.615) amongst all raters.
Site-based raters were also trained to use audio-digital
recording pens for the BPRS interview (Targum and
Pendergrass, 2014). All patients consented to audio-digital
recording of site-based BPRS interviews as part of their
consent to participate in the study. The audio-digital pens
simultaneously record the site-based interview and digitally
capture accompanying written notes on specially manufac-
tured source books. The recorded BPRS interviews were
electronically forwarded to Clintara LLC (Boston, MA) for
random assignment to the site-independent reviewers. The
S.D. Targum et al.314site-independent raters met the same ratings qualiﬁcation
standards as the site-based raters. Site-independent raters
were blinded to the study visit and trial site and generated
their “dual” scores by listening to the audio recording and
reading the site-based rater's corroborative digital notes.
Independent raters were blinded to the site-based rater's
scores because the digital notes sent to the blinded rater did
not include these scores.
As part of the QA surveillance program, we examined
BPRS scoring variance and absolute discordance between
the “dual” site-based rater scores and the paired site-inde-
pendent rater scores. Absolute discordance reﬂects the
deviation of site-independent scores from the paired site-
based BPRS scores in either direction. These “dual” scoring
analyses were performed in “real-time” on 100% of the
screen and stabilization visits in order to identify site-based
rater's who revealed excessive “dual” scoring deviations
(“outliers”) early in the study. Rater remediation was ini-
tiated when a second, independent rater conﬁrmed the
discordant total BPRS scores. Remediation included tele-
phone adjudication to discuss the speciﬁc score differences,
individual item deviations, and interview style. These raters
were followed to ascertain their subsequent performance
and were subject to removal from the study if it did not
improve. In addition to these analyses, we timed the length
of the full BPRS interview conducted by site-based raters in
order to determine whether length had an impact on the
quality of interviews and “dual” scoring concordance.
We examined visits 1 and 2 separately and as a pooled
group of paired interviews independent of the rater who did
the interview or that actual patient assessed. Statistical
analysis of the data included ICC, χ2, Student's t test, kappa
statistics, and one-way analysis of variance (ANOVA) using
the online VassarStats program.3. Results
3.1. Site-based total BPRS scores
Forty-three site-based raters recorded 228 BPRS screen visits
and 164 BPRS stabilization visits (n=392). The mean symptom
severity scores as measured by the total BPRS were relatively
stable without any statistically signiﬁcant difference between
the screen and stabilization visits (Table 1). The mean site-
based total BPRS score was 50.477.2 (SD) at the screen visit
and 50.577.0 (SD) at the stabilization visit (t=0.129; p=
0.90). The scores ranged from 39 to 81 (screen) and 39 to 75
(stabilization visit). The pooled total BPRS for both visitsTable 1 Comparison of total BPRS “dual” scores between site
n Site-based BPRS S
Screen (visit 1) 228 50.477.2 4
Stabilization (visit 2)a 164 50.577.0 4
All BPRS interviews 392 50.477.2 4
aA stabilization visit was conducted a minimum of 14 days after t
visits as part of the study eligibility criteria.combined was 50.477.2 (SD) for all 392 paired interviews
available for this analysis.
3.2. Comparison of site-based and site-
independent total BPRS scores
We compared the total BPRS “dual” scores between site-
based and site-independent raters (Table 1). The paired
“dual” scores were highly correlated at both visits (r=0.812
for both visits combined; t=35.31; po0.0001). Similar to
the stability of the site-based scores, the “dual” site-ind-
ependent scores were also stable between visits 1 and 2
(t=0.13; p=0.90). However, the site-independent raters
mean total BPRS scores were signiﬁcantly lower than site-
based raters at each visit (t=2.24; p=0.025 for both visits
combined).
There were individual scoring differences (deviations) bet-
ween the site-based and paired site-independent total BPRS
scores. The site-based scores deviated between 14 points
lower and 20 points higher than the site-independent “dual”
scores (Figure 1).
3.3. BPRS interview length
The audio-digital recording method made it possible to time
the length of each BPRS interview. The interviews ranged in
length from 7:25 to 59:44 min across the two visits. The
mean length of all 392 interviews combined was 21:057
7:47 min (median interview length=21 min). There was no
signiﬁcant difference in interview length between the two
interviews. The mean screen visit interview length (v1) was
20:3477:41 min and the mean stabilization visit interview
length (v2) was 21:5077:52 min (t=1.58; p=0.11).
Eighty nine BPRS interviews (23%) were conducted in less
than 15 min whereas the other 303 interviews (77%) took at
least 15 min to complete. The shorter interviews had sign-
iﬁcantly lower mean total BPRS scores than the longer site-
based interviews that took at least 15 min (t=2.34;
p=0.020). Alternatively, as shown in Table 2, the mean site-
based BPRS scores from the shorter interviews were actually
signiﬁcantly higher than the “paired” site-independent sco-
res (t=2.71; p=0.007).
There was a modest, but signiﬁcant correlation (ICC) betw-
een interview length and symptom severity as measured by
the total BPRS at these two visits (r=0.253; t=6.14; po
0.0001). This correlation was present in the 303 interviews
that took at least 15 min (r=0.263; t=4.56; po0.0001) but
not in the shorter interviews (r=0.057; t=0.4; p=0.690).-based and site-independent raters.
ite-independent BPRS r t p
9.577.1 0.809 1.34 0.182
9.077.3 0.82 1.88 0.061
9.277.2 0.812 2.24 0.025
he screen visit to assess and conﬁrm symptom stability between
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variance and discordance
The least “dual” scoring variance between site-based and site-
independent BPRS scores occurred in interviews that were
conducted between 20 and 24 min (Figure 2). The variance
increased as the interviews became shorter or longer.Figure 1 Total BPRS scoring deviations betwee
Table 2 BPRS interview length and ratings precision: impact o
n Length (minutes) Site-b
All BPRS interviewsa 392 21.177.8 50.47
Interview length
o15 min 89 11.772.0 48.87
Z15 min 303 23.476.9 50.87
aIncludes all BPRS visits from the screen and stabilization visits.
Figure 2 “Dual” scoring variance relativTable 3 displays the mean BPRS scoring variance, mean
absolute discordance, and discordance rates between the
“dual” BPRS scores at the screen and stabilization visits.
We established a cut-off range of Z8 BPRS points as an
arbitrary discordance range for “dual” scoring deviations
based upon 41SD of the mean total BPRS score (77.2) for
all BPRS interviews. The cut-off range is useful to identifyn site-based and site-independent raters*.
f “short” interviews.
ased BPRS Site-independent BPRS t p
7.2 49.277.2 2.24 0.025
6.1 46.475.8 2.71 0.007
7.4 50.177.4 1.29 0.200
e to BPRS interview length (n=392).
S.D. Targum et al.316raters who might need ratings remediation. Using this range,
35 of the 392 interviews (8.9%) were discordant and were
evenly distributed between the two visits (Table 3). Fifteen
of these discordant “dual” scores (42.8%) were conducted in
less than 15 min (“short” interviews). Shorter interviews
were signiﬁcantly more likely to be discordant than inter-
views that took at least 15 min to conduct (χ2=8.89; df=1;
p=0.003).
There was a signiﬁcantly greater “dual” scoring variance
(p=0.0016) and absolute mean scoring discordance (p=
0.0037) amongst the “short” BPRS interviews that were
conducted in less than 15 min compared to longer interviews
(Table 4). In contrast to the “short” interviews, longer BPRS
interviews that took more than 35 min to complete did not
reveal signiﬁcant scoring variance or absolute discordance.
Many shorter interviews (less than 15 min) were character-
ized by fewer questions asked and less information collected.
Blinded raters indicated that they were often uncertain about
the best “short” interview scores because of poor rater
performance and not because of poor patient cooperation.
On the other hand, longer interviews were mixed between
difﬁcult patients who were hard to examine (providing tan-
gential or evasive responses) and inexperienced interviewers
who took longer to get the necessary information.
3.5. Individual raters and “dual” scoring
variability
At part of the QA surveillance program, the impact of BPRS
interview length on “dual” scoring discordance was reviewed
throughout the enrollment process. At the approximate mid-
point (after 208 “dual” BPRS reviews), three of 43 site-based
raters were identiﬁed who accounted for nearly 40% of the
short interviews that had been conducted at the screen visit at
that time (visit 1). Of note, these three “outlier” raters had
more scoring discordance when they conducted “short” inter-
views than on their own longer interviews. The raters wereTable 3 Variance and absolute discordance comparison of BP
raters.
n Mean variance of “Dual” scoring d
Screen (visit 1) 228 19.7274.44
Stabilization (visit 2) 164 18.5374.31
aThe discordance rate reﬂects the number of paired “dual” scores
total BPRS score (50.477.2 points).
Table 4 Impact of “short” BPRS interviews on scoring varianc
n BPRS “dual” sco
All BPRS interviewsa 392 19.374.4
Interviews o15 min 89 26.275.1
Interviews Z15 min 303 16.774.1
ANOVA “short” vs. longer interviews F=10.05
p=0.0016
aIncludes all BPRS visits from the screen and stabilization visits.remediated, one was removed from the study, and the overall
performance of the other two improved.
In the ﬁnal review of the 392 available BPRS interviews
reported in this analysis, the “short” interviews were now dis-
tributed amongst all of the site-based raters and no individual
clinician-rater stood out as an “outlier” rater.
4. Discussion
Audio-digital recordings of site-based BPRS interviews were
used as part of a quality assurance surveillance program that
allowed us to examine ratings reliability (precision) and its
relationship to BPRS interview length. In this analysis, “dual”
scoring of the site-based BPRS interviews by paired blinded,
site-independent ratings revealed a high correlation (r=0.812)
and minimal discordance at the screen and stabilization visits
of a schizophrenia trial. This ﬁnding demonstrates that bli-
nded, site-independent raters can conﬁrm the total BPRS sco-
res of most, but not all audio-digital recorded interviews.
Interview length had a signiﬁcant impact on “dual” scoring
concordance. Shorter interviews (o15 min) revealed signiﬁ-
cantly more absolute discordance than longer interviews (p=
0.0037) and had signiﬁcantly greater “dual” scoring variance
(p=0.0016) as well.
In this study, the “sweet” spot for the least discordance
were BPRS interviews that were conducted between 20 and
24 min. Obviously, this ﬁnding does not mean that all compe-
tent BPRS interviews must be conducted within 20–24 min.
There are some interviews that require more time to complete
and others that might be sufﬁcient when conducted in less
than 20 min. The key point is that a research interview must
seek to obtain complete information at each visit and not rely
on previous interviews or presumptions to achieve reliable sco-
res. Although the shorter interviews yielded signiﬁcantly less
severe total BPRS scores than interviews that took at least
15 min (p=0.020), this difference cannot explain the variance
observed between site-based and site-independent ratings ofRS “dual” scores between site-based and site-independent
eviations Mean absolute discordance Discordance ratea
3.5072.86 19 (8.3%)
3.5072.86 16 (9.8%)
at each visit that exceed one standard deviation from the mean
e and absolute discordance.






317Impact of BPRS interview length on ratings reliability in a schizophrenia trialthe same interview. The BPRS instrument used in this study was
a structured version that provides prompt questions for each
item and tends to increase inter-rater reliability (Lukoff et al.,
1986; Ventura et al., 1993; Crippa et al., 2001). A review of
many of the shorter interviews revealed that the interviewer
asked fewer questions and thus less information (data) was
collected. Therefore, it is understandable that blinded raters
were not able to conﬁrm the scores as well as they did with
longer, more complete interviews. Some of the longer BPRS
interviews (435 min) revealed more discordance than the mid-
range length interviews but did not yield signiﬁcant “dual”
scoring differences. Longer interviews were often a conse-
quence of more difﬁcult patients (tangentiality, evasiveness) or
extra time taken by a less experienced rater. Other factors that
might affect interview quality and ratings reliability such as
rater experience with the BPRS, patient cooperation, the day
of the interview, or even the time of the day were not syst-
ematically examined in this study.
The analysis in this study used the BPRS interviews that
were conducted at two pre-randomization visits. In other
schizophrenia studies, we have found that shorter PANSS
interviews (less than 15 min) will also yield signiﬁcantly
greater absolute discordance and “dual” scoring variability
than longer interviews between site-based and site-indep-
endent raters (Targum et al., 2014).
The audio-digital recording method used in this study
serves as a constant reminder to site-based raters to
conduct complete interviews. By turning on the recording
pen the site-based raters obviously knew that they were
being “observed” during the interview. It is reasonable to
assume that the mere awareness of being observed would
alter site-based ratings behavior in most raters (e.g.
Hawthorne effect) and therefore assure data integrity
(McCarney et al., 2007). Yet, despite the obvious fact of
recording their own in-study BPRS interviews, some raters
still conducted short, insufﬁcient interviews. Clearly, pre-
study rater training and certiﬁcation did not guarantee in-
study ratings performance. In fact, some site-based raters
revealed greater “dual” scoring discordance when they did
“short” interviews relative to their own longer interviews.
Apparently, these raters were able to conduct scorable,
complete interviews when they took the time to do it.
Clearly, time is an issue in a busy research or clinic setting
and may, in some instances compromise the quality (com-
petency) of the interview. It is noteworthy that in-study
rater remediation abetted subsequent ratings performance
and these raters later acknowledged that some of their
interviews had been rushed.
A peripheral, but vitally important issue emerges about
the requisite length of a reliable rating instrument and the
necessary length of a research study visit. Recently, some
researchers have explored using shorter forms of rating
instruments in an effort to sustain ratings reliability without
the burden of long interviews (Levine, 2013; Levine and
Leucht, 2013; Velthorst et al., 2013). Clearly, long inter-
views and long clinic visits are burdensome to both the
patient and staff and can potentially saturate the patient
such that data accuracy is compromised. Further, long study
visits extend patient exposure to study staff and potentially
introduce placebo effects related to familiarity and other
non-drug beneﬁts of study participation. Although a briefer
interview and study visit is certainly desirable, our ﬁndingsreinforce the need for sufﬁcient interview length to obtain
enough data to generate reliable ratings.
In summary, our ﬁndings in this study suggest that some,
but not all “short” BPRS interviews are insufﬁcient because
they are incomplete. We have also found that shorter PANSS
interviews yield greater “dual” scoring discordance between
site-based and site-independent (Targum et al., 2014).
“Dual” scoring of site-based interviews using the audio-
digital recording method is a relative straightforward way to
reinforce ratings competency and a direct way to afﬁrm that
site-based raters have really conducted complete interviews.
Each surveillance strategy used in randomized clinical trials
has advantages and limitations. Audio recording is a less
intrusive method of surveillance than video observations and
“dual” ratings of site-based interviews are deﬁnitely less
burdensome than entirely separate, second interviews. How-
ever, a limitation of the audio-digital recording method is that
the blinded, independent scores are entirely dependent on the
quality of the site-based interview and the responses of the
patient to the site-based interviewer. Further, “dual” con-
cordance can provide scoring conﬁrmation but cannot demon-
strate that either the site-based or independent score is truly
accurate. Of course, the scoring accuracy of psychiatric
symptoms is an elusive target for any ratings method. Alter-
native surveillance methods, like separate telephone inter-
views or live video-fed interviews conducted by an indep-
endent rater offer a more distinct “second” opinion but have
inherent limitations as well (Shen et al., 2008; Schoemaker
et al., 2009; Targum et al., 2013). Separate (“second”)
telephone-based interviews are time consuming to arrange,
add cost and burden to the study visits, require a greater level
of patient cooperation and participation than a recorded ﬁrst
interview, and introduce temporal and informational variance
about symptom severity that will likely generate different
scores. Each of these surveillance methods, as well as patient-
reported outcomes and site-based ratings represent different
data “sourcing” that will inﬂuence the scores.
The current study examines ratings precision but does not
examine the impact of “dual” ratings on treatment out-
come. Additional studies that examine other rating instru-
ments, the relevance of interview length and “dual” scoring
concordance throughout a clinical trial, and the impact of
“dual” ratings on trial outcome are needed. Meanwhile, the
audio-digital recording method applied in this study is a
relatively unobtrusive surveillance strategy whose use in
multi-site randomized clinical trials may assure rater per-
formance and enhance ratings precision.
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